Cargando…
Fear of disease progression in carriers of the m.3243A > G mutation
BACKGROUND: Being diagnosed with mitochondrial disease due to the m.3243A > G mutation is frequently preceded by a long diagnostic process. The disease itself is characterized by heterogeneous course and expression, so leaving patients with considerable uncertainty regarding their prognosis and t...
Autores principales: | Custers, José A. E., de Laat, Paul, Koene, Saskia, Smeitink, Jan, Janssen, Mirian C. H., Verhaak, Christianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234600/ https://www.ncbi.nlm.nih.gov/pubmed/30424784 http://dx.doi.org/10.1186/s13023-018-0951-y |
Ejemplares similares
-
Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation
por: Verhaak, Christianne, et al.
Publicado: (2016) -
Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant
por: Klein, Inge‐Lot, et al.
Publicado: (2022) -
Quantification of gait in mitochondrial m.3243A > G patients: a validation study
por: Ramakers, Rob, et al.
Publicado: (2017) -
Erratum to: Quantification of gait in mitochondrial m.3243A > G patients: a validation study
por: Ramakers, Rob, et al.
Publicado: (2017) -
The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders
por: Janssen, Mirian C.H., et al.
Publicado: (2018)